- New Purchases: COIN, XPEV, NRIX, FULC,
- Added Positions: PDD,
- Reduced Positions: IVV, AGG,
- Sold Out: DOCU, SNOW, CRSP, DELL, JNCE,
For the details of Mass General Brigham, Inc's stock buys and sells, go to https://www.gurufocus.com/guru/mass+general+brigham%2C+inc/current-portfolio/portfolio
These are the top 5 holdings of Mass General Brigham, Inc- iShares Core S&P 500 ETF (IVV) - 468,707 shares, 54.48% of the total portfolio. Shares reduced by 9.65%
- iShares Core U.S. Aggregate Bond ETF (AGG) - 1,158,777 shares, 35.90% of the total portfolio. Shares reduced by 8.43%
- Coinbase Global Inc (COIN) - 128,947 shares, 7.91% of the total portfolio. New Position
- Pinduoduo Inc (PDD) - 44,184 shares, 1.08% of the total portfolio. Shares added by 24.99%
- XPeng Inc (XPEV) - 38,370 shares, 0.37% of the total portfolio. New Position
Mass General Brigham, Inc initiated holding in Coinbase Global Inc. The purchase prices were between $220.61 and $280.47, with an estimated average price of $246.56. The stock is now traded at around $248.140000. The impact to a portfolio due to this purchase was 7.91%. The holding were 128,947 shares as of 2021-09-30.
New Purchase: XPeng Inc (XPEV)Mass General Brigham, Inc initiated holding in XPeng Inc. The purchase prices were between $34.55 and $44.05, with an estimated average price of $39.76. The stock is now traded at around $37.660000. The impact to a portfolio due to this purchase was 0.37%. The holding were 38,370 shares as of 2021-09-30.
New Purchase: Nurix Therapeutics Inc (NRIX)Mass General Brigham, Inc initiated holding in Nurix Therapeutics Inc. The purchase prices were between $22.71 and $36.69, with an estimated average price of $30.82. The stock is now traded at around $27.560000. The impact to a portfolio due to this purchase was 0.13%. The holding were 15,904 shares as of 2021-09-30.
New Purchase: Fulcrum Therapeutics Inc (FULC)Mass General Brigham, Inc initiated holding in Fulcrum Therapeutics Inc. The purchase prices were between $7.28 and $30.97, with an estimated average price of $18.95. The stock is now traded at around $26.480000. The impact to a portfolio due to this purchase was 0.12%. The holding were 15,860 shares as of 2021-09-30.
Added: Pinduoduo Inc (PDD)Mass General Brigham, Inc added to a holding in Pinduoduo Inc by 24.99%. The purchase prices were between $74.69 and $121.84, with an estimated average price of $97.66. The stock is now traded at around $96.220000. The impact to a portfolio due to this purchase was 0.22%. The holding were 44,184 shares as of 2021-09-30.
Sold Out: DocuSign Inc (DOCU)Mass General Brigham, Inc sold out a holding in DocuSign Inc. The sale prices were between $256.89 and $310.05, with an estimated average price of $288.31.
Sold Out: Snowflake Inc (SNOW)Mass General Brigham, Inc sold out a holding in Snowflake Inc. The sale prices were between $236.75 and $324.08, with an estimated average price of $284.09.
Sold Out: CRISPR Therapeutics AG (CRSP)Mass General Brigham, Inc sold out a holding in CRISPR Therapeutics AG. The sale prices were between $110.2 and $156.64, with an estimated average price of $126.
Sold Out: Dell Technologies Inc (DELL)Mass General Brigham, Inc sold out a holding in Dell Technologies Inc. The sale prices were between $92.29 and $105.38, with an estimated average price of $98.36.
Sold Out: Jounce Therapeutics Inc (JNCE)Mass General Brigham, Inc sold out a holding in Jounce Therapeutics Inc. The sale prices were between $5.04 and $8.73, with an estimated average price of $6.2.
Here is the complete portfolio of Mass General Brigham, Inc. Also check out:
1. Mass General Brigham, Inc's Undervalued Stocks
2. Mass General Brigham, Inc's Top Growth Companies, and
3. Mass General Brigham, Inc's High Yield stocks
4. Stocks that Mass General Brigham, Inc keeps buying